Webinar: Venture Capital 101

OSAGE UNIVERSITY PARTNERS PRESENTS: VENTURE CAPITAL 101 PLEASE JOIN US FOR AN INFORMATIONAL SESSION ON THE WORLD OF VENTURE CAPITAL: HOW THEY OPERATE, HOW THEY GENERATE VALUE, AND HOW TO EFFECTIVELY WORK WITH THEM.  IN-PERSON:  IN-PERSON ATTENDEES ARE WELCOME TO JOIN US IN THE UC SAN DIEGO BIOMEDICAL RESEARCH FACILITY 2 (BRF2), 2A03  CONFERENCE ROOM, ON JUNE 26, 2019 FROM 12:00-1:30PM. LUNCH WILL BE PROVIDED 30 MINUTES BEFORE THE EVENT BEGINS.  CLOSEST PARKING IS THE OSLER PARKING STRUCTURE ON THE CORNER OF GILMAN DRIVE AND OSLER LANE ONLINE:  ATTENDEES CAN CHOOSE TO ACCESS THE EVENT REMOTELY THROUGH ZOOM, ONE TAP MOBILE, OR SKYPE FOR BUSINESS. JOIN BY ZOOM MEETING: HTTPS://UCSD.ZOOM.US/J/517161974 [https://ucsd.zoom.us/j/517161974] ONE TAP MOBILE:         +16699006833,,517161974# US (SAN JOSE)        +16465588656,,517161974# US (NEW YORK) JOIN BY SKYPE FOR BUSINESS: HTTPS://UCSD.ZOOM.US/SKYPE/517161974 [https://ucsd.zoom.us/skype/517161974] SPEAKER: MATT COHEN  MATT JOINED OUP IN 2013 AND FOCUSES ON INVESTMENTS IN THERAPEUTICS, DIAGNOSTICS, MEDICAL DEVICES, AND RESEARCH TOOLS. HE HAS BEEN INVOLVED WITH OUP’S INVESTMENT IN SEVERAL PORTFOLIO COMPANIES INCLUDING KURA ONCOLOGY (NASDAQ: KURA), SPERO THERAPEUTICS (NASDAQ: SPRO), CELL DESIGN LABS (ACQUIRED BY GILEAD), BIOHAVEN PHARMA (NYSE: BHVN), ARRAKIS THERAPEUTICS, ANTIVA BIOSCIENCES, PMV PHARMA, AND OTHERS. PRIOR TO JOINING OUP, MATT WAS A STRATEGY CONSULTANT WITH L.E.K. CONSULTING SERVING CLIENTS IN BIOPHARMA, DIAGNOSTICS, RESEARCH TOOLS, HEALTHCARE, AND PRIVATE EQUITY. ENGAGEMENTS INCLUDED STRATEGY DEVELOPMENT, MARKET ASSESSMENT, COMMERCIALIZATION SUPPORT, PORTFOLIO DEVELOPMENT, ACQUISITION TARGET IDENTIFICATION, AND DILIGENCE / TRANSACTION SUPPORT. AS A PH.D. STUDENT AT THE UNIVERSITY OF PENNSYLVANIA MATT CONDUCTED RESEARCH ON THE ANTIBODY RESPONSE TO A NOVEL PROTEIN-BASED POXVIRUS VACCINE AND ADVISED SEVERAL STARTUPS WHILE WORKING WITH THE PENN BIOTECH GROUP. ORGANIZED BY: RESEARCH AFFAIRS, OFFICE OF INNOVATION & COMMERCIALIZATION (OIC) OIC STAFF WILL BE IN ATTENDANCE FOR LICENSING AND COMMERCIALIZATION QUESTIONS. FOR MORE INFO, EMAIL US AT: INNOVATION@UCSD.EDU